Early Access — free while we kick the tires
EdgarHawk

Scilex Holding Co

10% Owner

10% Owner
3 filings analyzed · 2 companies · Latest 2026-01-14

Never miss a filing from Scilex Holding Co

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Datavault AI Inc. DVLT 0 2 Net selling
Semnur Pharmaceuticals, Inc. SMNR 0 1 Net selling

Activity

January 2026
2026-01-14 Datavault AI Inc. DVLT
high
Sell
15,965,541 shares
$13,215,896
Significance 7/10

10% owner Scilex Holding sells 15.97M shares at blended $0.83, down -78.6% from 52-week high; unprofitable company

Scilex Holding, a 10% owner, executed three separate sales totaling 15,965,541 shares for $13,215,896.16 on 2026-01-12 through 2026-01-14 at prices ranging from $0.72 to $0.91 (blended average $0.83). This represents a -6.9% reduction in holdings from 229,731,770 to 213,766,229 shares. The sales occurred as the stock trades at $0.72 current price, reflecting a -78.6% decline from its 52-week high of $3.36 and a -42.8% drop over the preceding 30 days. The company remains unprofitable (latest quarter net income: $-32,976,000.00) despite annual revenue growth of 28.4%, indicating significant cash burn. The recent and rapid sequence of three same-ticker sales within a 3-day window in early January, combined with the stock's severe multi-month deterioration and the company's persistent losses, suggests heightened liquidity management by a major shareholder during a period of material weakness.

2026-01-08 Datavault AI Inc. DVLT
high
Sell
14,713,490 shares
$18,176,455
Significance 7/10

Scilex Holding Co sold 14,713,490 shares (6.0% of holdings) across 3 days for $18,176,455.30 at $1.24 avg; stock now -69.9% from 52-week high.

Scilex Holding Co, a 10% stakeholder in Datavault AI, executed 3 separate sales totaling 14,713,490 shares (14.71M shares) for $18,176,455.30 between January 6-8, 2026, at an average blended price of $1.24. The company currently trades at $1.01, down 34.6% in the last 30 days and down 46.0% over 90 days, moving dramatically from its 52-week high of $3.36. Against this backdrop, the seller is carrying a substantial remaining position of 229,731,770 shares (229.73M shares), and Datavault AI remains unprofitable with a negative net income of $-32,976,000.00 against quarterly revenue of $2,904,000.00. The timing of this 6.0% reduction in holdings during a period of steep stock decline, combined with the company's ongoing losses and weak profitability, raises questions about conviction levels and capital allocation priorities among the major investor base.

September 2025
2025-09-25 Semnur Pharmaceuticals, Inc. SMNR Joint filing
high
Sell
12,500,000 shares
$200,000,000
Significance 8/10

Scilex Holding Co sold 12,500,000 shares (96.2% reduction) at $16.00 for $200,000,000 in 2 separate transactions.

A 10% owner executed two separate sales totaling 12,500,000 shares for $200,000,000, reducing its stake from 13,000,000 shares to 500,000 shares—a 96.2% reduction in holdings. The transactions occurred at $16.00 per share while current price is $19.00, and this follows a very recent listing (2 trading days), meaning the company is newly public and traditional liquidity/performance history is not yet established. The company generated Revenue $50,000,000 in the latest quarter with a Net income of $-385,122 and posted zero annual revenue growth (FY vs prior FY), indicating unprofitability over the most recent full fiscal year. The near-complete exit by a controlling shareholder during the immediate post-IPO window—when shares priced at $16.00 but now trade at $19.00—warrants close examination of the founder's confidence in the business trajectory and capital allocation priorities.

Related insiders